Side-by-side comparison of AI visibility scores, market position, and capabilities
Premium home goods holding company with $7.5B revenue; Williams-Sonoma cookware, Pottery Barn, and West Elm with 65%+ digital revenue competing with Wayfair and RH.
Williams-Sonoma, Inc. is a premium specialty retail holding company operating some of the most recognized home goods brands in the United States — including Williams-Sonoma (cookware and kitchen), Pottery Barn (home furnishings), Pottery Barn Kids, Pottery Barn Teen, West Elm (modern home furnishings), and Rejuvenation (lighting and hardware). Listed on NYSE (NYSE: WSM) and headquartered in San Francisco, California, Williams-Sonoma generates approximately $7.5 billion in annual revenue and is notable for generating over 65% of its revenue through direct-to-consumer digital channels — one of the highest e-commerce penetration rates among specialty retailers.\n\nWilliams-Sonoma, Inc. (the parent company and cookware brand) focuses on culinary enthusiasts with high-quality cookware (All-Clad, Le Creuset), bakeware, kitchen gadgets, outdoor grills, and tableware. The brand's stores and catalog have long been the reference point for serious home cooks seeking premium kitchen equipment. Williams-Sonoma's cooking classes, chef collaborations, and culinary content position the brand as an authority rather than just a retailer.\n\nIn 2025, Williams-Sonoma, Inc. as a holding company has outperformed most specialty retailers through disciplined inventory management, strong direct-to-consumer digital capabilities, and a brand portfolio that spans multiple home lifestyle segments. The company competes with IKEA, Crate & Barrel, RH, Wayfair, and Amazon Home for home goods spending. Williams-Sonoma's B2B trade business (selling to interior designers and commercial developers) has grown significantly. CEO Laura Alber's strategy through 2025 emphasizes digital investment, brand differentiation, international expansion (Australia, UK, and franchise growth), and growing the business-to-design professional trade channel.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.